Bruker Completes Acquisition of Socabim
News Jan 18, 2006
Bruker AXS GmbH has announced that it has completed the acquisition of privately-held Socabim SAS. This acquisition was originally announced on August 16, 2005, and was expected to close early in 2006.
The acquisition of Socabim significantly expands Bruker AXS’ core technology base in two of its strategic product and applications areas.
It is expected that the addition of the Socabim technology and R&D team will further improve the "time-to-market," the analytical power of Bruker AXS’ X-ray systems for advanced research and process analysis in the nanomaterials, thin film, composite materials, semiconductor and basic materials industries.
Nanoparticles show great promise as diagnostic tools and drug delivery agents. But until now, most nanoparticles had to be injected into the bloodstream because they weren’t absorbed well orally. Now, researchers have modified nanoparticles to improve their uptake in the gastrointestinal tract.